Your browser doesn't support javascript.
Basophils and Mast Cells in COVID-19 Pathogenesis.
Murdaca, Giuseppe; Di Gioacchino, Mario; Greco, Monica; Borro, Matteo; Paladin, Francesca; Petrarca, Claudia; Gangemi, Sebastiano.
  • Murdaca G; Clinical Immunology Unit, Department of Internal Medicine, University of Genoa and Ospedale Policlinico San Martino, 16132 Genoa, Italy.
  • Di Gioacchino M; Center for Advanced Studies and Technology, G' d'Annunzio University, 66100 Chieti, Italy.
  • Greco M; Institute for Clinical Immunotherapy and Advanced Biological Treatments, 65100 Pescara, Italy.
  • Borro M; Internal Medicine Department, San Paolo Hospital, 17100 Savona, Italy.
  • Paladin F; Internal Medicine Department, San Paolo Hospital, 17100 Savona, Italy.
  • Petrarca C; Department of Internal Medicine, University of Genoa, Ospedale Policlinico San Martino IRCCS, 16132 Genoa, Italy.
  • Gangemi S; Center for Advanced Studies and Technology, G' d'Annunzio University, 66100 Chieti, Italy.
Cells ; 10(10)2021 10 14.
Article in English | MEDLINE | ID: covidwho-1470798
ABSTRACT
Basophils and mast cells are among the principal inducers of Th2 responses and have a crucial role in allergic and anti-parasitic protective immunity. Basophils can function as antigen-presenting cells that bind antigens on their surface and boost humoral immune responses, inducing Th2 cell differentiation. Their depletion results in lower humoral memory activation and greater infection susceptibility. Basophils seem to have an active role upon immune response to SARS-CoV-2. In fact, a coordinate adaptive immune response to SARS-CoV-2 is magnified by basophils. It has been observed that basophil amount is lower during acute disease with respect to the recovery phase and that the grade of this depletion is an important determinant of the antibody response to the virus. Moreover, mast cells, present in a great quantity in the nasal epithelial and lung cells, participate in the first immune response to SARS-CoV-2. Their activation results in a hyperinflammatory syndrome through the release of inflammatory molecules, participating to the "cytokine storm" and, in a longer period, inducing pulmonary fibrosis. The literature data suggest that basophil counts may be a useful prognostic tool for COVID-19, since their reduction is associated with a worse prognosis. Mast cells, on the other hand, represent a possible therapeutic target for reducing the airway inflammation characteristic of the hyperacute phase of the disease.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Basophils / COVID-19 / Mast Cells Type of study: Prognostic study Limits: Animals / Humans Language: English Year: 2021 Document Type: Article Affiliation country: Cells10102754

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Basophils / COVID-19 / Mast Cells Type of study: Prognostic study Limits: Animals / Humans Language: English Year: 2021 Document Type: Article Affiliation country: Cells10102754